HESI evolve practice exam questions with
accurate solutions
an |antacid |(Maalox) |is |prescribed |for |a |client |with |peptic |ulcer |disease. |the |nurse |knows |that |
the |purpose |of |this |medicatio |is:
A. |decrease |production |of |gastric |secretions
B. |produce |an |adherent |barrier |over |the |ulcer
C. |maintain |a |gastric |pH |of |3.5 |or |higher
D. |decrease |gastric |motor |activity |- |CORRECT |ANSWER✔✔-C. |maintain |a |gastric |pH |of |3.5 |or |
higher
rationale: |objective |of |antacids |is |to |neutralize |gastric |acids |and |keep |a |pH |of |3.5 |or |above, |
which |is |necessary |for |pepsinogen |activity
In |evaluation |the |effects |of |lactulose |(Cephulac), |which |outcome |would |indicate |that |the |drug |
is |performing |as |intended?
A. |increase |in |urine |output
B. |2 |or |3 |soft |stools |per |day.
C. |watery, |diarrhea |stools
D. |increased |serum |bilirubin |- |CORRECT |ANSWER✔✔-B. |2 |or |3 |soft |stools |per |day.
The |healthcare |provider |prescribes |digitalis |(Digoxin) |for |a |client |diagnosed |with |CHF. |which |
intervention |should |the |nurse |implement |prior |to |administering |Digoxin?
A. |observe |respiratory |rate |and |depth
B. |assess |serum |potassium |level
,C. |obtain |the |client's |BP
D. |Monitor |the |serum |glucose |level |- |CORRECT |ANSWER✔✔-B. |assess |serum |potassium |level
Following |the |administration |of |sublingual |nitroglycerin |to |a |client |experiencing |an |acute |
anginal |attack, |which |assessment |finding |indicates |to |the |nurse |that |the |desired |effect |has |
been |achieved?
A. |client |states |chest |pain |is |relieved
B. |client's |pulse |decreases |from |120 |to |90
C. |client's |systolic |BP |decreases |from |180 |to |90.
D. |clients |Oxygen |level |increases |form |92% |to |96% |- |CORRECT |ANSWER✔✔-A. |client |states |
chest |pain |is |relieved
A |client |with |CHF |is |being |discharges |with |a |new |prescription |for |ACE |inhibitor |Captopril |
(Capoten). |The |nurse's |discharge |instruction |should |include |reporting |which |problem |to |the |
health |care |provider?
A. |weight |loss
B. |Dizziness
C. |Muscle |cramps
D. |Dry |mucous |membreanes |- |CORRECT |ANSWER✔✔-B. |Dizziness
A |client |is |being |treated |for |hyperthyroidism |with |propylthiouracil |(PTU). |The |nurse |knows |that
|the |action |of |this |drug |is |to:
A. |decrease |the |amount |of |thyroid-stimulating |hormone |circulating |in |the |blood.
B. |increase |the |amount |of |thyroid-stimulating |hormone |circulating |in |the |blood.
C. |increase |the |amount |of |T4 |and |decrease |the |amount |of |T3 |produced |by |the |thyroid.
D. |inhibit |synthesis |of |T3 |and |T4 |by |the |thyroid |glanf |- |CORRECT |ANSWER✔✔-D. |inhibits |
synthesis |of |T3 |and |T4 |by |the |thyroid |gland.
, A |client |with |Parkinson's |disease |is |taking |carbidopa-levadopa |(Sinemet). |which |observation |by
|the |nurse |would |indicate |that |the |desired |outcome |of |the |medication |is |being |achieved?
A. |decreased |BP
B. |lessening |of |tremors
C. |increased |salivation
D. |increased |attention |span |- |CORRECT |ANSWER✔✔-B. |lessening |of |tremors
rationale: |sinemet |carbidopa |increases |the |amount |of |levodopa |to |the |CNS |(dopamine |to |the |
brain). |increased |amounts |of |dopamine |improve |the |symptoms |of |Parkinsons, |such |as |
involuntary |movements, |resting |tremors, |shuffling |air, |etc. |dec |drooling |would |be |a |desired |
effect |of |levodopa/carbidopa
Following |heparin |treatment |for |a |pulmonary |embolism, |a |client |is |being |discharged |with |a |
prescription |for |warfarin |(coumadin). |In |conducting |discharge |teaching, |the |nurse |advises |the |
client |to |have |which |diagnostic |test |monitored |regularly |after |discharge? |
A. |perfusion |scan
B. |Prothrombin |Time |(PT/INR)
C. |activated |partial |thromboplastin |(APPT)
D. |serum |coumadin |level |(SCL). |- |CORRECT |ANSWER✔✔-B. |prothrombin |time |(PT/INR)
rationale: |when |used |for |a |client |with |a |pulmonary |embolus, |the |theraputic |goal |for |warfarin |
therapy |is |1-2x |greater |than |the |control, |Orr |an |INR |of |2-3
A |postoperative |client |has |been |receiving |a |continuous |IV |infusion |of |meperidine |(demerol) |
35mg/hr |for |four |days. |the |client |has |a |PRN |prescription |for |Demerol |100 |mg |PO |q3h. |The |
nurse |notes |that |the |client |has |become |increasingly |restless, |irritable |and |confused, |stating |
that |there |are |bugs |all |over |the |walls. |what |action |should |the |nurse |take |first?
A. |administer |a |PRN |dose |of |PO |meperidine |(Demerol).
B. |administer |naloxone |(Narcan) |IV |per |PRN |protocol/
accurate solutions
an |antacid |(Maalox) |is |prescribed |for |a |client |with |peptic |ulcer |disease. |the |nurse |knows |that |
the |purpose |of |this |medicatio |is:
A. |decrease |production |of |gastric |secretions
B. |produce |an |adherent |barrier |over |the |ulcer
C. |maintain |a |gastric |pH |of |3.5 |or |higher
D. |decrease |gastric |motor |activity |- |CORRECT |ANSWER✔✔-C. |maintain |a |gastric |pH |of |3.5 |or |
higher
rationale: |objective |of |antacids |is |to |neutralize |gastric |acids |and |keep |a |pH |of |3.5 |or |above, |
which |is |necessary |for |pepsinogen |activity
In |evaluation |the |effects |of |lactulose |(Cephulac), |which |outcome |would |indicate |that |the |drug |
is |performing |as |intended?
A. |increase |in |urine |output
B. |2 |or |3 |soft |stools |per |day.
C. |watery, |diarrhea |stools
D. |increased |serum |bilirubin |- |CORRECT |ANSWER✔✔-B. |2 |or |3 |soft |stools |per |day.
The |healthcare |provider |prescribes |digitalis |(Digoxin) |for |a |client |diagnosed |with |CHF. |which |
intervention |should |the |nurse |implement |prior |to |administering |Digoxin?
A. |observe |respiratory |rate |and |depth
B. |assess |serum |potassium |level
,C. |obtain |the |client's |BP
D. |Monitor |the |serum |glucose |level |- |CORRECT |ANSWER✔✔-B. |assess |serum |potassium |level
Following |the |administration |of |sublingual |nitroglycerin |to |a |client |experiencing |an |acute |
anginal |attack, |which |assessment |finding |indicates |to |the |nurse |that |the |desired |effect |has |
been |achieved?
A. |client |states |chest |pain |is |relieved
B. |client's |pulse |decreases |from |120 |to |90
C. |client's |systolic |BP |decreases |from |180 |to |90.
D. |clients |Oxygen |level |increases |form |92% |to |96% |- |CORRECT |ANSWER✔✔-A. |client |states |
chest |pain |is |relieved
A |client |with |CHF |is |being |discharges |with |a |new |prescription |for |ACE |inhibitor |Captopril |
(Capoten). |The |nurse's |discharge |instruction |should |include |reporting |which |problem |to |the |
health |care |provider?
A. |weight |loss
B. |Dizziness
C. |Muscle |cramps
D. |Dry |mucous |membreanes |- |CORRECT |ANSWER✔✔-B. |Dizziness
A |client |is |being |treated |for |hyperthyroidism |with |propylthiouracil |(PTU). |The |nurse |knows |that
|the |action |of |this |drug |is |to:
A. |decrease |the |amount |of |thyroid-stimulating |hormone |circulating |in |the |blood.
B. |increase |the |amount |of |thyroid-stimulating |hormone |circulating |in |the |blood.
C. |increase |the |amount |of |T4 |and |decrease |the |amount |of |T3 |produced |by |the |thyroid.
D. |inhibit |synthesis |of |T3 |and |T4 |by |the |thyroid |glanf |- |CORRECT |ANSWER✔✔-D. |inhibits |
synthesis |of |T3 |and |T4 |by |the |thyroid |gland.
, A |client |with |Parkinson's |disease |is |taking |carbidopa-levadopa |(Sinemet). |which |observation |by
|the |nurse |would |indicate |that |the |desired |outcome |of |the |medication |is |being |achieved?
A. |decreased |BP
B. |lessening |of |tremors
C. |increased |salivation
D. |increased |attention |span |- |CORRECT |ANSWER✔✔-B. |lessening |of |tremors
rationale: |sinemet |carbidopa |increases |the |amount |of |levodopa |to |the |CNS |(dopamine |to |the |
brain). |increased |amounts |of |dopamine |improve |the |symptoms |of |Parkinsons, |such |as |
involuntary |movements, |resting |tremors, |shuffling |air, |etc. |dec |drooling |would |be |a |desired |
effect |of |levodopa/carbidopa
Following |heparin |treatment |for |a |pulmonary |embolism, |a |client |is |being |discharged |with |a |
prescription |for |warfarin |(coumadin). |In |conducting |discharge |teaching, |the |nurse |advises |the |
client |to |have |which |diagnostic |test |monitored |regularly |after |discharge? |
A. |perfusion |scan
B. |Prothrombin |Time |(PT/INR)
C. |activated |partial |thromboplastin |(APPT)
D. |serum |coumadin |level |(SCL). |- |CORRECT |ANSWER✔✔-B. |prothrombin |time |(PT/INR)
rationale: |when |used |for |a |client |with |a |pulmonary |embolus, |the |theraputic |goal |for |warfarin |
therapy |is |1-2x |greater |than |the |control, |Orr |an |INR |of |2-3
A |postoperative |client |has |been |receiving |a |continuous |IV |infusion |of |meperidine |(demerol) |
35mg/hr |for |four |days. |the |client |has |a |PRN |prescription |for |Demerol |100 |mg |PO |q3h. |The |
nurse |notes |that |the |client |has |become |increasingly |restless, |irritable |and |confused, |stating |
that |there |are |bugs |all |over |the |walls. |what |action |should |the |nurse |take |first?
A. |administer |a |PRN |dose |of |PO |meperidine |(Demerol).
B. |administer |naloxone |(Narcan) |IV |per |PRN |protocol/
